Headquartered in Texas, MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation Platform (Paired VNS™ Platform), based on decades of neuroscience research. The Vivistim® System, for treatment of post-stroke upper limb mobility issues, is the first FDA-approved system on the platform. MicroTransponder is researching ways to expand the Paired VNS™ platform to help patients with other chronic neurologic conditions.